Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells
2017 · Cancer Discovery · 280 citations
https://doi.org/10.1158/2159-8290.cd-17-0538
R
Robin Parihar
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
93
Papers
2.8K
Citations
25
h-index
34
i10-index
Robin Parihar is an academic researcher from Houston Methodist. The author has contributed to research in topics: Immune Cell Function and Interaction & CAR-T cell therapy research & T-cell and B-cell Immunology. The author has an h-index of 25, co-authored 80 publications.
ORCID: 0000-0002-3283-6713Papers by this author
worksIL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells
2002 · Journal of Clinical Investigation · 180 citations
https://doi.org/10.1172/jci15950
Interleukin-2 enhances the natural killer cell response to Herceptin-coated Her2 /neu-positive breast cancer cells
2001 · European Journal of Immunology · 154 citations
https://doi.org/10.1002/1521-4141(2001010)31:10<3016::aid-immu3016>3.0.co;2-j
Interleukin-21 Enhances NK Cell Activation in Response to Antibody-Coated Targets
2006 · The Journal of Immunology · 118 citations
https://doi.org/10.4049/jimmunol.177.1.120
A Phase I Study of Interleukin 12 with Trastuzumab in Patients with Human Epidermal Growth Factor Receptor-2-Overexpressing Malignancies
2004 · Clinical Cancer Research · 111 citations
https://doi.org/10.1158/1078-0432.ccr-04-0265
IL-12 Enhances the Antitumor Actions of Trastuzumab via NK Cell IFN-γ Production
2011 · The Journal of Immunology · 98 citations
https://doi.org/10.4049/jimmunol.1000328
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat